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ABSTRACT 61 
Objectives: To explore factors affecting communication between Foundation Year (FY) 1 doctors and hospital 62 
pharmacists about prescribing from the junior doctors’ perspective. 63 
Methods: Trained interviewers (n=4) conducted semi-structured interviews with FY1 doctors who were 64 
purposively sampled from three hospitals in England. FY1 doctors were asked about: their experiences of 65 
communication with hospital pharmacists about their prescribing; instances where they disagreed with or did 66 
not implement a hospital pharmacist’s recommendation; and their preferences for communicating with hospital 67 
pharmacists about prescribing. Interviews were audio-recorded, transcribed verbatim and analysed thematically.  68 
Results: A total of 27 FY1 doctors were interviewed. Findings were categorized into four main themes: (i) 69 
nature and context of communication; (ii) FY1 doctors’ perceptions of communication with hospital 70 
pharmacists; (iii) factors influencing FY1 doctors’ decision whether to act on pharmacists’ prescribing 71 
recommendations; and (iv) suggestions to improve communication with pharmacists. FY1 doctors and hospital 72 
pharmacists generally communicated well. FY1 doctors appreciated and frequently acted upon pharmacists’ 73 
advice yet there was deference to senior medical staff when advice differed. Joint ward rounds, pharmacist-led 74 
teaching sessions and a standardised approach to communication were all suggested as ways to improve 75 
communication and may increase the likelihood of pharmacists’ recommendations being acted upon. 76 
Conclusions: FY1 doctors and hospital pharmacists communicated frequently about medication prescribing. 77 
Issues occurred when there were differences in professional judgment between senior medical staff and 78 
pharmacists but these were usually resolved satisfactorily for the FY1 doctor. Further interventions to improve 79 
communication and safe prescribing could involve a multi-disciplinary and systems approach.  80 
INTRODUCTION 81 
Communication problems between healthcare professionals (HCPs), such as doctors and pharmacists, are 82 
prevalent and known to contribute to medication errors.[1] In particular, poor communication has been 83 
identified as one factor that can affect prescribing errors.[2] Studies have already explored communication 84 
between doctors and pharmacists in primary care from both professionals’ perspectives,[3-6] but there is a lack 85 
of research investigating communication between doctors and pharmacists in secondary care,[7] particularly 86 
from the junior (Foundation Year (FY) 1) doctors' (doctors in their first year of training post-graduation) 87 
perspective with whom pharmacists have frequent contact. 88 
 89 
Studies in primary care settings in several countries have shown doctors act upon pharmacist’s 90 
recommendations 46-100% of the time (median 79%),[8-12] but it is unknown why this variation exists and 91 
why doctors do not act upon pharmacists’ recommendations. These findings suggest there may be unaddressed 92 
issues with communication that could be improved. Primary care research found doctors’ negative attitudes 93 
towards pharmacists [3-4] and their lack of appreciation for pharmacists’ skills [5-6] can cause communication 94 
problems; for example, no feedback following pharmacists' recommendations and a disinterest in collaboration 95 
from doctors. Poor communication between FY1 doctors and hospital pharmacists has also been identified as a 96 
barrier to effective feedback.[13] 97 
 98 
A previous study found FY1 doctors made the most prescribing errors, but since they are generally responsible 99 
for the majority of prescribing it could not be assumed that they make more prescribing errors than senior 100 
doctors (registrars and consultants).[14] A more recent study found that FY1 doctors were twice as likely to 101 
make a prescribing error compared to consultants.[15] FY1 doctors have previously said that one-way 102 
communication with little discussion and few opportunities for learning contributed to prescribing errors,[2] 103 
suggesting better communication may reduce prescribing errors and improve medication safety.  104 
 105 
Exploring FY1 doctors’ views of communication with hospital pharmacists is important to further add to the 106 
knowledge base of communication between doctors and pharmacists. Identifying factors that facilitate or hinder 107 
communication could help inform strategies to reduce prescribing errors and improve pharmaceutical care.   108 
Therefore, the aim of this study was to explore factors affecting communication between FY1 doctors and 109 
hospital pharmacists about prescribing issues from the FY1 doctors’ perspective.  110 
 111 
METHODS 112 
Study Design 113 
This study used semi-structured interviews with FY1 doctors in a secondary care setting to elicit information 114 
about their communication with hospital pharmacists about their prescribing. The semi-structured approach 115 
allowed participants to openly discuss their experiences of communication with hospital pharmacists, whilst 116 
retaining emphasis on the areas of interest. This study received ethical approval from the University of Reading 117 
Research Ethics Committee (ref 12/12). 118 
 119 
Development of Interview Schedule 120 
Interview questions were developed from relevant literature and with discussion between the interprofessional 121 
research team (who consisted of pharmacists and doctors with extensive experience of medication errors and 122 
their causes). Three core questions were developed, with prompts to encourage discussion. The first question 123 
asked about FY1 doctors’ last three conversations with hospital pharmacists about their prescribing. The second 124 
question asked about instances where the FY1 doctor disagreed with or did not implement a hospital 125 
pharmacist’s recommendation, and the final question asked about FY1 doctors’ preferences for communicating 126 
with hospital pharmacists about their prescribing. Questions deliberately avoided asking directly about 127 
communication problems to allow doctors to identify what they perceived to be problems and to avoid talking 128 
specifically about prescribing errors. The questions were tested in a small pilot study of FY1 doctors and did not 129 
identify any issues, thus no changes were made to the questions for this study. The interview questions used in 130 
this study are summarized in Box 1.  131 
 132 
Recruitment of Participants 133 
In order to participate in this study, participants had to be an FY1 doctor working at a hospital in England. A 134 
convenience sample of FY1 doctors was identified via existing contacts at three acute hospital trusts in England 135 
(Oxford, Reading, and Manchester). These doctors were sent information letters via email inviting them to 136 
participate in the study. Members of the research team also recruited FY1 doctors by attending FY1 doctor 137 
training days. Interviews were conducted with all participants who agreed to participate in the study until data 138 
saturation was reached. Written informed consent was sought from participants prior to data collection.  139 
 140 
Data Collection 141 
Four researchers (pre-registration pharmacists and undergraduate pharmacy students) who had received 142 
appropriate training conducted one-on-one audio-recorded interviews (n=27) between November 2012 and June 143 
2013. Interviews were conducted in-person at the hospital site or via teleconferencing facilities at the University 144 
according to the preference of the FY1 doctor being interviewed. Interviewers introduced themselves and their 145 
role (pharmacy student or pre-registration pharmacist) at the start of the interview.  146 
 147 
Data Analysis 148 
Two researchers transcribed interview recordings verbatim. Another independent researcher analysed the data 149 
using thematic analysis aided by QSR International’s NVivo version 10 (2012) qualitative data management 150 
software. Data were coded, and similar codes grouped into categories to identify themes. The analysis process 151 
was iterative and the researcher referred back to previous points as new observations became apparent. Another 152 
trained researcher independently coded a third (nine) of the interview transcripts. On comparison, the two code 153 
lists provided a good match with 94% agreement. Minor differences were discussed between the two researchers 154 
until agreement was reached.  155 
 156 
RESULTS 157 
Participant demographics 158 
A total of 27 participants across the three hospital sites were recruited and interviewed. All FY1 doctors who 159 
responded were interviewed. Participants worked in general medicine (n=15), general surgery (n=9) and 160 
unknown (n=3) settings at the time of the interview. Participants’ time in their current post varied from a few 161 
days to four and a half months so some participants drew on their previous experiences working in other settings 162 
when interviewed. Interviews lasted between four and 16 minutes.  163 
 164 
Themes identified 165 
Thematic analysis identified four main themes described below: 1) Nature and context of communication; 2) 166 
perceptions of communication with hospital pharmacists; 3) factors influencing doctors’ decision whether to act 167 
on pharmacists’ recommendations; and 4) suggestions to improve communication with pharmacists. 168 
 169 
Nature and context of communication 170 
Both FY1 doctors and hospital pharmacists initiated communication about prescribing. FY1 doctors usually 171 
approached pharmacists before prescribing for advice such as interpreting guidelines or calculating doses, whilst 172 
hospital pharmacists contacted doctors after medications were prescribed or after reviewing patients’ blood test 173 
results, for example to suggest an alternative medicine or dose. Many FY1 doctors said they had regular contact 174 
with hospital pharmacists, whilst only a couple reported few or intermittent communications with hospital 175 
pharmacists, usually when the doctor was working nights. Reported frequency of communication with hospital 176 
pharmacists varied depending on the time of day, with fewer interactions occurring out of hours (evenings, 177 
nights and weekends): 178 
“We’ve got a pharmacist who comes quite regularly, almost everyday in the mornings.” (I11) 179 
 180 
The doctors’ speciality also affected communication frequency, for example doctors on a medical rotation 181 
reported communicating more frequently with hospital pharmacists compared to those on a surgical rotation. 182 
FY1 doctors reported that they communicated most frequently with hospital pharmacists in their first post, and 183 
that this contact reduced as they became more experienced: 184 
“I found the pharmacists really useful on stroke especially at the beginning, because when you’re new 185 
you don’t know your doses.” (I18)  186 
 187 
Perceptions of communication with hospital pharmacists 188 
FY1 doctors described pharmacists positively and commented that pharmacists were helpful, had excellent 189 
knowledge of medicines, always willing to answer questions and approachable: 190 
 “Pharmacists that I’ve worked with … have been fantastic and really approachable, happy to have 191 
questions, don’t make you feel stupid when you don’t know things and a really valuable resource.” (I6)  192 
 193 
Participants described how they worked closely with hospital pharmacists and many commented positively on 194 
their interactions describing communication using words such as ‘clear’, ‘helpful’ and ‘pleasant’. FY1 doctors 195 
also commented that knowing the names of pharmacists aided communication by getting to know the 196 
pharmacists better and establishing rapport within the multidisciplinary team, which ultimately helped doctors' 197 
understanding of pharmacists’ recommendations. It was apparent from the interviews that pharmacists’ provided 198 
FY1 doctors with a safety net for their prescribing and that this provided reassurance to these newly qualified 199 
prescribers: 200 
“I feel like they [the pharmacists] are a really nice safety check…I am comforted knowing it's there.” 201 
(I3) 202 
 203 
Conversely, some FY1 doctors provided examples of unhelpful communication. FY1 doctors expressed how 204 
communication with pharmacists could sometimes become frustrating, inconvenient and repetitive (especially 205 
true if several pharmacists were involved in a prescribing scenario), and that communication with pharmacists 206 
may not be a priority when they have other tasks to complete:  207 
“You’re trying to do an important job and your eleventh bleep is from a pharmacist … sometimes in 208 
the context of lots of other demands made upon you it would be nice not to have that extra bleep.” (I4) 209 
 210 
One participant also raised timing of communication by pharmacists as an issue:    211 
“He takes quite un-opportune times to talk to you … it’s just a timing issue.” (I13) 212 
 213 
Despite these negative comments, doctors acknowledged the information given by pharmacists may be useful in 214 
the future or to someone else. 215 
 216 
Factors influencing doctors’ decision whether to act on pharmacists’ recommendations 217 
FY1 doctors described how they would discuss pharmacists’ recommendations one to one to ensure they 218 
understood the advice and to resolve any misunderstandings. FY1 doctors appreciated and generally agreed with 219 
pharmacists’ prescribing advice, accepting their recommendations. On other occasions, FYI doctors came to a 220 
mutual agreement over the correct course of action with the pharmacist: 221 
“I thought it was very important to discuss these issues, especially if there is a risk of prescribing 222 
error.” (I19) 223 
 224 
The trust that doctors placed in pharmacists prompted doctors to act on their recommendations and facilitated 225 
two-way communication: 226 
“Nice for the pharmacist to pick that up … I completely trust pharmacists.” (I23) 227 
 228 
Those occasions in which FY1 doctors did not act on pharmacists’ recommendations were explored during the 229 
interviews. It emerged that a divergence between senior doctors’ and pharmacists’ professional opinions would 230 
commonly lead to a deference to the opinion of senior doctors; senior doctors were more experienced and FY1 231 
doctors did not wish to challenge their decisions: 232 
“They [the consultants] have more wisdom than I do so I usually take their advice.” (I3). 233 
 234 
Additionally, there were a small number of occasions in which FY1 doctors did not act on pharmacists’ 235 
recommendations:  236 
“They’ve suggested ‘why don’t we try this’ and we’ve said ‘well actually no we’re not doing that 237 
because of x, y, z’.” (I6) 238 
 239 
Suggestions to improve communication with pharmacists 240 
FY1 doctors made suggestions for how pharmacists could improve the likelihood of their recommendations 241 
being acted upon, as summarized in Box 2.  242 
 243 
FY1 doctors suggested greater access to pharmacists would be helpful, especially out of regular working hours, 244 
as they felt pharmacists could be difficult to find, pharmacy departments could be slow and their phones always 245 
busy. FY1 doctors indicated the lack of continuity of staff to be an issue and preferred a dedicated, regular ward 246 
pharmacist who could be approached for advice when necessary, which would reduce repetitive, time-247 
consuming conversations caused by different pharmacists’ covering ward rounds: 248 
“It would be better if the ward pharmacists were more ward based so they were always there … at the 249 
moment it’s a bit sporadic when you see them.” (I13) 250 
 251 
Some FY1 doctors outlined the benefits of having pharmacists on ward rounds, an existing practice in some 252 
hospitals that enables pharmacists to review patients’ medications together as part of a multidisciplinary team:  253 
“I’ve seen in other hospitals and from past experience, the pharmacists actually do ward rounds with 254 
the consultant as an extra member of the team. I think that’s much better and a very sensible system.” 255 
(I9) 256 
 257 
FY1 doctors in the study raised concerns about guidelines and protocols that were difficult to interpret or 258 
contained conflicting information. In addition it was felt that there was a lack of protocols, for example, in the 259 
administration of medicines. It was suggested that unclear guidelines and protocols could be reviewed to 260 
improve the decision-making process and address FY1 doctors' concerns:  261 
“Our department doesn’t have a protocol for one medication that we commonly use … from our point 262 
of view if we could sort out a departmental protocol it would be even more helpful and would solve all 263 
of these problems.” (I9) 264 
 265 
FY1 doctors would welcome more pharmacist-led teaching sessions on basic prescribing skills such as how to 266 
prescribe on a medicine chart or how to calculate values such as creatinine clearance: 267 
“I think that teaching session was really good. So more of them.” (I23)  268 
 269 
Data suggests that implementing a consistent communication method between hospital pharmacists and FY1 270 
doctors could increase the likelihood of pharmacists’ recommendations being implemented by FY1 doctors. 271 
Some doctors preferred verbal communication, others written communication and some a combination of both 272 
verbal and written communication. However, there was no unanimous agreement over which was preferred.  273 
 274 
DISCUSSION 275 
Our study found FY1 doctors communicate well with hospital pharmacists but suggested that communication 276 
between hospital pharmacists and senior doctors was less collaborative. Hospital pharmacists’ input was 277 
generally appreciated and their prescribing recommendations acted upon, except some instances where FY1 278 
doctors acted on senior doctors’ advice instead. Suggestions for improving communication include greater 279 
access to pharmacists, joint ward rounds and more pharmacist-led teaching sessions.  280 
 281 
FY1 doctors described several positive aspects of communication between themselves and hospital pharmacists. 282 
Trusting and knowing each other has been found to improve communication between doctors and pharmacists 283 
in primary care [3-4, 16-17] and the findings of our study suggest this may also be the case in secondary care 284 
since FY1 doctors preferred to work with regular ward pharmacists who they could become acquainted with, 285 
rather than irregular or part-time pharmacists. However, when faced with different advice FY1 doctors would 286 
usually defer to senior doctors' recommendations rather than the pharmacists’, which may be because doctors 287 
work in a hierarchical structure and FY1 doctors do not want to upset the team relationship.[18] Further work 288 
could explore the role of trust in decision-making and communication between healthcare professionals.  289 
 290 
FY1 doctors said pharmacists ensured effective and safe prescribing; an important finding that concurs with a 291 
previous study and demonstrates the impact of pharmacists’ skills.[19] FY1 doctors in this study valued and 292 
were confident to act on pharmacists' prescribing recommendations or mutually agree an acceptable course of 293 
action. However, FY1 doctors said that some senior doctors would continue to act on their own experience, 294 
rather than the pharmacists’ recommendations.  295 
 296 
Our study found doctors usually discussed pharmacists' prescribing recommendations, which supports the 297 
findings of a recent study that found 85% of issues identified by pharmacists were discussed with the doctor and 298 
the rest were discussed with nurses or medical students.[20] Discussions with healthcare professionals other 299 
than doctors may explain why conversations between pharmacists and doctors did not occur in some instances 300 
and account for why pharmacists’ recommendations were not acted upon. 301 
 302 
Our study found that poor timing of pharmacy queries from pharmacists was a problem. Doctors and 303 
pharmacists have already agreed the need for greater collaboration to improve pharmaceutical care.[21] 304 
Developing a relationship based on mutual understanding of competing priorities, and agreeing upon the most 305 
appropriate mode of communication and optimal timing of communication are important next steps. In addition, 306 
joint ward rounds could potentially reduce communication problems between FY1 doctors and hospital 307 
pharmacists, such as misinterpreting communication and difficulty contacting each other, as prescribing queries 308 
would be resolved at the time of prescribing. Joint ward rounds have already been shown to optimise decision-309 
making,[22] reduce medication errors,[23-24] and decrease medicine-related problems.[25] However, joint ward 310 
rounds require both the doctor and the pharmacist to be available at the same time, which could prove 311 
challenging given that doctors' heavy workload has previously been identified as a barrier to 312 
communication.[26] 313 
 314 
FY1 doctors appreciated pharmacists teaching basic skills such as how to prescribe, and would like more of this. 315 
Since the time of the study, there has been progress in this area; the Royal College of Physicians in the United 316 
Kingdom has introduced guidance that recommends prescribing induction should be practically focussed and 317 
cover safety principles, and that junior doctors should receive regular feedback on prescribing errors in a 318 
structured and supportive way.[27] Pharmacists teaching FY1 doctors in a hospital setting resulted in a 37.5% 319 
reduction in prescribing errors,[28] which highlights the value of pharmacists’ skills in improving 320 
pharmaceutical care. Previous studies have found junior doctors acknowledged their lack of prescribing 321 
skills[29] and only 38%[30] of FY1 doctors considered themselves competent to prescribe at graduation. This 322 
explains the desire for this service, although improvements in teaching and assessing prescribing competence at 323 
medical schools could reduce this need in the future. Since the time of the study, there has been technological 324 
advances in the way prescribing is undertaken in acute hospitals for example a switch from paper-based to 325 
electronic prescribing. Future studies could investigate whether such changes influence communication about 326 
prescribing. 327 
 328 
There were some limitations of this study. First, three study sites were used which is more representative of the 329 
study population than a single site but not wholly representative of the entire population. Second, distinctions 330 
were not made between doctor specialties or the pharmacist’s level of experience, although a wide sample of 331 
pharmacists from across the three hospitals should have captured differences in experience and communication 332 
skills. Comparing communication between different specialties of doctor may identify communication problems 333 
that are inherent to one group rather than all junior doctors. Third, interviews were short with some interviewees 334 
only detailing one example rather than several; despite this data saturation was achieved.  335 
 336 
CONCLUSION 337 
FY1 doctors and hospital pharmacists communicated frequently, and both approach each other for different 338 
reasons. The majority of FY1 doctors appreciated input from hospital pharmacists about their prescribing, but 339 
where the senior doctor and hospital pharmacists’ recommendations differed, FY1 doctors would defer to the 340 
senior doctor’s advice. FY1 doctors’ suggestions to improve communication such as joint ward rounds and 341 
more pharmacist-led teaching sessions have the potential to decrease prescribing errors and improve medication 342 
safety. Agreement on the most appropriate mode and timing of communication are important next steps. Future 343 
development of interventions to reduce prescribing errors could take into account the multi-factorial issues 344 
identified in this study. 345 
 346 
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Key messages 411 
What is already known on this subject 412 
 Communication problems between doctors and pharmacists exist, but there is a lack of information 413 
about communication between FY1 doctors and hospital pharmacists from the FY1 doctors’ 414 
perspective.  415 
 Poor communication between FY1 doctors and hospital pharmacists may lead to prescribing errors.  416 
What this study adds 417 
 FY1 doctors and hospital pharmacists communicate frequently about prescribing 418 
 FY1 doctors valued pharmacists input and usually acted on pharmacists' prescribing recommendations, 419 
unless the senior doctor had a different recommendation.  420 
 Joint ward rounds, improving prescribing guidelines and more pharmacist-led teaching sessions could 421 
improve communication 422 
 423 
 424 
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 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
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Box 1. Interview questions used in the study. 
1. Can you tell me about the last three conversations you had with a pharmacist about your 
prescribing? 
Who started the conversation? 
What was the conversation was about? 
What was particularly good or helpful about this conversation? 
What would have improved the conversation (on the part of the doctor or the pharmacist)? 
2. Can you think of an instance where a pharmacist has recommended a change in medication 
that you disagreed with or didn’t implement? 
What was the recommendation? 
How was the recommendation made (written note, conversation, in medical notes etc.)? 
Why did you disagree with the recommendation? 
Why did you choose not to implement the recommendation? 
Was the rationale for this decision discussed with the pharmacist (why/why not)? 
3. When a pharmacist gives you advice about (or queries) your prescribing, do you prefer them 
to talk to you about it, or to write it down for you? 
Why is this form of communication preferred? 
If written, where would you prefer it to be written? 
If verbal, do you prefer face to face or telephone communication? 
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Box 2. Suggestions to improve communication between junior doctors and pharmacists. 
 Greater access to pharmacists 
 Joint ward rounds 
 Guidelines review 
 Pharmacist teaching sessions 
 Standardised communication methods 
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